Hasil Pencarian - Arindam Dhar

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: A semimechanistic autoinduction model

    Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: A semimechanistic autoinduction model oleh Anu Shilpa Krishnatry, Alexander Voelkner, Arindam Dhar, Marita Prohn, Geraldine Ferron‐Brady

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Exposure–response analysis of adverse events associated with molibresib and its active metabolites in patients with solid tumors

    Exposure–response analysis of adverse events associated with molibresib and its active metabolites in patients with solid tumors oleh Anu Shilpa Krishnatry, Eva Hanze, Tim Bergsma, Arindam Dhar, Marita Prohn, Geraldine Ferron‐Brady

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    390 A global, molecular disease characterization initiative (MDCI) in oncology clinical trials

    390 A global, molecular disease characterization initiative (MDCI) in oncology clinical trials oleh Jeffrey Weber, Hassane Zarour, David Carbone, Marcus Butler, Roma Patel, Melissa Johnson, Adrian Sacher, Edward Garon, Arindam Dhar, Cristina Messina, Kristin Blouch, Axel Hoos, Anne-Marie Martin

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 therapy

    596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 thera... oleh Antoni Ribas, Mohammed Milhem, Diwakar Davar, Patricia LoRusso, Zeynep Eroglu, Martin Gutierrez, Arindam Dhar, Carlos Becerra, Brian Di Pace, Tianli Wang, Hailei Zhang, Srimoyee Ghosh, Shyam Srivats, Theo Borgovan, Angela Waszak

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

    Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia oleh Charles C. Bell, Katie A. Fennell, Yih-Chih Chan, Florian Rambow, Miriam M. Yeung, Dane Vassiliadis, Luis Lara, Paul Yeh, Luciano G. Martelotto, Aljosja Rogiers, Brandon E. Kremer, Olena Barbash, Helai P. Mohammad, Timothy M. Johanson, Marian L. Burr, Arindam Dhar, Natalie Karpinich, Luyi Tian, Dean S. Tyler, Laura MacPherson, Junwei Shi, Nathan Pinnawala, Chun Yew Fong, Anthony T. Papenfuss, Sean M. Grimmond, Sarah-Jane Dawson, Rhys S. Allan, Ryan G. Kruger, Christopher R. Vakoc, David L. Goode, Shalin H. Naik, Omer Gilan, Enid Y. N. Lam, Jean-Christophe Marine, Rab K. Prinjha, Mark A. Dawson

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: